• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Silo Pharma Inc (NQ: SILO )

    1.130 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Silo Pharma Inc

    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    Psyched: Canada's Case For Psilocybin Access And Microdose Trial, US Reform Update, Battle With DEA & More
    Canadian Patients Demand Access To Psilocybin: Federal Lawsuit, Official Petition & Failing Mechanism A patient-led lawsuit against the Canadian government is claiming access to therapeutic psilocybin... 
    Via Benzinga
    Silo Pharma Inc. (NASDAQ: SILO) Provides Update on Innovative Study Looking into the Feasibility of Using Ketamine Formulations as an Alternative Treatment for Fibromyalgia
    Via Investor Brand Network
    Silo Pharma To Patent Novel Ketamine-Based Treatment For Chronic Condition
    Biopharma company Silo Pharma Inc. 
    Via Benzinga
    PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Files Patent for Treatment of Fibromyalgia
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property Product Safety
    Silo Pharma Announces filing of Patent for Treatment of Fibromyalgia
    From Silo Pharma, Inc.
    Via GlobeNewswire
    PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Positioned as Frontrunner in Psychedelic Drugs Market
    Via Investor Brand Network
    Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More
    Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
      On Tuesday, 74 companies achieved new lows for the year. 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Psychedelic Trials Update: Treating Meth Addiction, Fibromyalgia & General Anxiety Disorder
    Three companies have provided updates on their efforts to assess different psychedelics for treating a widely varied set of conditions. 
    Via Benzinga
    PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Positive Results from IND-Enabling Toxicology Study of SP-26
    Via Investor Brand Network
    Exposures Product Safety
    Silo Pharma Announces Positive Results from IND-Enabling Study of SP-26 for Fibromyalgia
    From Silo Pharma, Inc.
    Via GlobeNewswire
    Silo Pharma Inc. (NASDAQ: SILO) Set to Benefit as Study Supports the Efficacy of Psychedelics in Treating ‘Drug-Resistant’ Depression
    Via Investor Brand Network
    Exposures COVID-19
    Here Are The Year's Highest Priced Psychedelics Stocks In US Markets
    After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.   
    Via Benzinga
    PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Expands Intellectual Property, Technology Rights for Treating Rare Stress-Related Medical Conditions
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    Stocks That Hit 52-Week Lows On Monday
      During Monday's session, 56 companies made new 52-week lows. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
      During Tuesday, 79 stocks hit new 52-week lows. 
    Via Benzinga
    Silo Pharma Inc. (NASDAQ: SILO) Granted US Patent For SPC-15 to Prevent and Treat Stress-Induced Disorders
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    BioMedNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Files Patent for Treatment of Alzheimer’s
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    Silo Pharma Announces Filing of Patent for Treatment of Alzheimer’s
    From Silo Pharma, Inc.
    Via GlobeNewswire
    BioMedNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Partnering to Transform Health Care, Improve Patient Outcomes
    Via Investor Brand Network
    Silo Pharma, Mindset Pharma, Terran Biosciences Receive Psychedelic Treatments Patents, IP Portfolios Expanded
    Silo Pharma Sees Growth In IP With New US Patent For Novel Ketamine Method On Stress-Induced Affective Disorders 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Expands IP Portfolio with New USPTO Patent
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    Silo Pharma Announces Expansion of Intellectual Property Portfolio
    Silo Receives Issuance of U.S. Patent Covering SPC-15 Method for Treatment and Prevention of Stress-Induced Affective Disorders 
    From Silo Pharma, Inc.
    Via GlobeNewswire
    PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Board Authorizes Stock Repurchase Program
    Via Investor Brand Network
    Silo Pharma Announces Stock Repurchase Program
    From Silo Pharma, Inc.
    Via GlobeNewswire
    Silo Pharma Inc. (NASDAQ: SILO) Provides Update on UCSF Psylocibin Clinical Trial
    Via Investor Brand Network
    PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Eying Broad Market Opportunities for Its Liposomal Joint Homing Peptide
    Via Investor Brand Network
    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.